EMulate Therapeutics, Inc.
EMulate - Indolor Therapeutics
Indolor Therapeutics is feasibility (phase I) trial ready for the treatment of acute and chronic pain by the application of specific pain-managing ulRFE fields, another expression of EMulate’s Therapeutic technology.
Most popular related searches
Preclinical testing for safety and effectiveness in humans and animals is complete.
Several different pain models were assessed.
Animal data show pain reduction greater than reference drugs in neuropathic pain model and noticeable activity in two other animal models.